Literature DB >> 781380

Classical complement pathway activation in membranoproliferative glomerulonephritis.

Y M Ooi, E H Vallota, C D West.   

Abstract

Levels of components of the classical and alternative complement pathways and the activity of the C3 nephritic factor (C3NeF) were measured in serum specimens from patients with type I (subendothelial deposits) and type II (intramembranous dense deposits) membranoproliferative glomerulonephritis (MPGN) and the results compared with the levels in normal subjects. Although C3 and C5 concentrations were comparably depressed in type I and type II, the levels of Clq and C4 were lower in type I and the correlation coefficients between Clq vs. C4 and C4 vs. C3 were higher than in type II. The profile was highly suggestive of classical pathway activation. In contrast, in type II MPGN, factor B levels were lower and C3NeF activity was more frequently detectable and higher. A feature of interest was that type I, as compared to type II, was characterized by significantly lower serum concentrations of properdin, higher and more significant correlation coefficients between serum properdin concentrations and those of Clq, C4 and C3, and consistent glomerular deposition of properdin. The involvement of properdin in type I may reflect recruitment of a pathway resembling the C1 bypass mechanism, said to involve C1, properdin, factor B and C3-9.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 781380     DOI: 10.1038/ki.1976.6

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

Review 1.  The quest for an intrinsic C3 activating factor in human glomerular disease.

Authors:  J L Roberts; E J Lewis
Journal:  Surv Immunol Res       Date:  1982

2.  Complement depletion accelerates the clearance of immune complexes from the circulation of primates.

Authors:  F J Waxman; L A Hebert; J B Cornacoff; M E VanAman; W L Smead; E H Kraut; D J Birmingham; J M Taguiam
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

3.  A possible association of partial lipodystrophy with anti-GBM nephritis (Goodpasture's syndrome).

Authors:  D R Blake; H Rashid; M McHugh; A R Morley
Journal:  Postgrad Med J       Date:  1980-02       Impact factor: 2.401

4.  Mesenchymal stem cells inhibit complement activation by secreting factor H.

Authors:  Zhidan Tu; Qing Li; Hong Bu; Feng Lin
Journal:  Stem Cells Dev       Date:  2010-08-01       Impact factor: 3.272

5.  Hereditary angio-oedema with mesangiocapillary glomerulonephritis.

Authors:  J Plaza; P Malasit; D N Kerr
Journal:  Postgrad Med J       Date:  1977-10       Impact factor: 2.401

6.  Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney.

Authors:  Y M Ooi; B S Ooi; E H Vallota; M R First; V E Pollak
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

7.  Glomerulonephritis with dense deposits: a variant of membranoproliferative glomerulonephritis or a separate morphological entity? Light, electron microscopic and immunohistochemical study of eleven cases.

Authors:  G Mazzucco; G Barbiano di Belgiojoso; R Confalonieri; R Coppo; G Monga
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

8.  Inhibition of C5 convertase by epsilon amino caproic acid (EACA): a limiting factor in the generation of C5a anaphylatoxin.

Authors:  E H Vallota
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

9.  Complement activation by circulating serum factors in human glomerulonephritis.

Authors:  S Meri
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

10.  Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in membranoproliferative glomerulonephritis type I.

Authors:  J Soma; T Saito; J Seino; H Sato; T Ootaka; A Yusa; K Abe
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.